查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1698596

醫藥包裝市場機會、成長動力、產業趨勢分析及2025-2034年預測

Pharmaceutical Packaging Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球醫藥包裝市場價值為 1,515 億美元，預計 2025 年至 2034 年期間的複合年成長率為 15.6%。對生物製藥的需求不斷成長以及對防篡改和兒童安全包裝的日益重視是推動成長的關鍵因素。生物製劑的進步和個人化醫療的激增加速了對確保穩定性和功效的專門包裝解決方案的需求。因此，各公司正加強研發力度，推出符合嚴格監管要求的創新材料和形式。

醫藥包裝市場 - IMG1

製藥業越來越依賴先進的包裝來保存複雜的生物製劑，這為製造商帶來了新的機會。低溫和溫度敏感包裝解決方案越來越受到關注，以滿足生物製藥的儲存和運輸需求。此外，對病人安全的高度關注和嚴格的法規正在促使公司投資於防止意外攝入的保護性包裝概念。製藥公司正在採用 RFID 追蹤和溫度指示器等智慧功能來提高藥物的可追溯性和依從性。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 1515億美元
預測值 6456億美元
複合年成長率 15.6%

市場分為初級包裝、二級包裝和三級包裝。預計到 2034 年，初級包裝的市場規模將超過 4,312 億美元。隨著製造商優先考慮藥品安全和合規性，對智慧和互動式包裝（包括兒童安全、防篡改解決方案）的需求正在增加。生物製劑和個人化醫療的擴展進一步推動了對維持產品完整性的高阻隔材料的需求。

根據材料，市場分為塑膠和聚合物、紙和紙板、玻璃和金屬。 2024 年，塑膠和聚合物佔據了總市場佔有率的 43.4%，因其多功能性、重量輕和耐用性而成為首選。永續性議題推動了生物基、可回收和可生物分解塑膠的採用，以減少對環境的影響並滿足不斷變化的監管標準。

市場也按產品類型細分，包括瓶子、注射器、泡殼包裝、小瓶和安瓿瓶、小袋、小袋和藥管。瓶子是該領域的佼佼者，2024 年市場規模達 453 億美元。由於瓶子方便易用，製藥業繼續青睞用於固體和液體藥物包裝的瓶子。向永續替代品（包括可回收和生物基塑膠瓶）的轉變反映了人們為減少生態足跡所做的持續努力。

根據應用，市場包括口服藥物、注射藥物、外用藥物、鼻腔藥物和靜脈注射藥物。 2024 年口服藥物包裝規模將達到 525 億美元，其中泡殼包裝、瓶子和小袋仍然是最常用的形式。增強型兒童安全設計和內建劑量追蹤指示器越來越受歡迎，有助於確保用藥依從性和安全性。

2024 年，北美以 34.8% 的市佔率領先全球醫藥包裝市場。僅美國就貢獻了 461 億美元，這得益於嚴格的監管框架以及對藥品生產和醫療保健進步的大量投資。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

  • 產業生態系統分析
  • 產業衝擊力
    • 成長動力
      • 新型藥品包裝系統不斷創新
      • 生物製藥需求不斷成長
      • 慢性病盛行率不斷上升
      • 擴大使用先進的藥物傳輸系統
      • 包裝中對兒童安全、防篡改功能的需求不斷成長
    • 產業陷阱與挑戰
      • 假藥和假包裝
      • 獲得優質醫療服務的機會有限或不足
  • 成長潛力分析
  • 監管格局
  • 技術格局
  • 未來市場趨勢
  • 差距分析
  • 波特的分析
  • PESTEL分析

第4章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 策略儀表板

第5章：市場估計與預測：依產品類型，2021 年至 2034 年

  • 主要趨勢
  • 泡殼包裝
  • 瓶子
  • 注射器
  • 小瓶和安瓿瓶
  • 小袋
  • 袋裝
  • 藥管
  • 其他

第6章：市場估計與預測：按材料，2021 年至 2034 年

  • 主要趨勢
  • 塑膠
    • 聚乙烯（PE）
    • 聚對苯二甲酸乙二醇酯（PET）
    • 聚丙烯（PP）
    • 聚苯乙烯（PS）
    • 聚氯乙烯（PVC）
    • 其他
  • 紙和紙板
  • 玻璃
  • 金屬

第7章：市場估計與預測：依包裝類型，2021 年至 2034 年

  • 主要趨勢
  • 初級包裝
  • 二次包裝
  • 三級包裝

第 8 章：市場估計與預測：按應用，2021 年至 2034 年

  • 主要趨勢
  • 口服藥物
  • 注射藥物
  • 外用藥物
  • 鼻腔藥物
  • 靜脈注射（IV）藥物
  • 其他

第9章：市場估計與預測：按地區，2021 年至 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國

第10章：公司簡介

  • Adelphi
  • Amcor
  • Aptar CSP Technologies
  • Berry Global
  • Catalent
  • CCL Industries
  • Comar
  • Constantia Flexibles
  • Drug Plastics & Glass
  • DS Smith
  • Eastman Chemical
  • Gerresheimer
  • Huhtamaki
  • Mayr-Melnhof Karton
  • Nipro
  • Origin Pharma Packaging
  • ProAmpac
  • Schott Pharma
  • SGD Pharma
  • Silgan
  • Sonoco
  • West Pharmaceutical
  • WestRock
簡介目錄
Product Code: 5256

The Global Pharmaceutical Packaging Market was valued at USD 151.5 billion in 2024 and is anticipated to expand at a CAGR of 15.6% from 2025 to 2034. The rising demand for biopharmaceuticals and the increasing emphasis on tamper-evident and child-resistant packaging are key factors driving growth. Advances in biologics and the surge in personalized medicine are accelerating the need for specialized packaging solutions that ensure stability and efficacy. As a result, companies are ramping up research and development efforts to introduce innovative materials and formats that align with stringent regulatory requirements.

Pharmaceutical Packaging Market - IMG1

The pharmaceutical industry's growing reliance on advanced packaging to preserve complex biological formulations presents new opportunities for manufacturers. Cryogenic and temperature-sensitive packaging solutions are gaining traction to address the storage and transportation needs of biopharmaceuticals. Additionally, the heightened focus on patient safety and stringent regulations are pushing companies to invest in protective packaging concepts that prevent accidental ingestion. Pharmaceutical firms are incorporating smart features such as RFID-enabled tracking and temperature indicators to improve drug traceability and adherence.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$151.5 Billion
Forecast Value$645.6 Billion
CAGR15.6%

The market is categorized into primary, secondary, and tertiary packaging. Primary packaging is projected to surpass USD 431.2 billion by 2034. The demand for smart and interactive packaging, including child-resistant and tamper-proof solutions, is increasing as manufacturers prioritize drug safety and compliance. The expansion of biologics and personalized medicine is further fueling the need for high-barrier materials that maintain product integrity.

Based on material, the market is divided into plastics and polymers, paper and paperboard, glass, and metal. Plastics and polymers accounted for 43.4% of the total market share in 2024, serving as the preferred choice due to their versatility, lightweight nature, and durability. Sustainability concerns are driving the adoption of bio-based, recyclable, and biodegradable plastics to reduce environmental impact and meet evolving regulatory standards.

The market is also segmented by product type, including bottles, syringes, blister packs, vials and ampoules, sachets, pouches, and medication tubes. Bottles led the segment, generating USD 45.3 billion in 2024. The pharmaceutical industry continues to favor bottles for solid and liquid drug packaging due to their convenience and ease of use. The shift toward sustainable alternatives, including recycled and bio-based plastic bottles, reflects growing efforts to minimize ecological footprint.

By application, the market includes oral drugs, injectable drugs, topical drugs, nasal drugs, and intravenous drugs. Oral drug packaging reached USD 52.5 billion in 2024, with blisters, bottles, and sachets remaining the most utilized formats. Enhanced child-resistant designs and built-in indicators to track dosages are gaining popularity, supporting medication adherence and safety.

North America led the global pharmaceutical packaging market with a 34.8% share in 2024. The United States alone contributed USD 46.1 billion, driven by strict regulatory frameworks and substantial investments in medicine production and healthcare advancements.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing innovation in novel drug packaging systems
      • 3.2.1.2 Rising demand for biopharmaceuticals
      • 3.2.1.3 Increasing prevalence of chronic diseases
      • 3.2.1.4 Increasing use of advanced drug delivery systems
      • 3.2.1.5 Rising demand for child-resistant and tamper-evident features in packaging
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Counterfeit drugs and fake packaging
      • 3.2.2.2 Limited or Inadequate access to quality medical care
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Future market trends
  • 3.7 Gap analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2034 (USD Bn & Kilo Tons)

  • 5.1 Key trends
  • 5.2 Blister packs
  • 5.3 Bottles
  • 5.4 Syringes
  • 5.5 Vials & ampoules
  • 5.6 Sachets
  • 5.7 Pouches
  • 5.8 Medication tubes
  • 5.9 Others

Chapter 6 Market Estimates and Forecast, By Material, 2021 – 2034 (USD Bn & Kilo Tons)

  • 6.1 Key trends
  • 6.2 Plastics
    • 6.2.1 Polyethylene (PE)
    • 6.2.2 Polyethylene terephthalate (PET)
    • 6.2.3 Polypropylene (PP)
    • 6.2.4 Polystyrene (PS)
    • 6.2.5 Polyvinyl chloride (PVC)
    • 6.2.6 Others
  • 6.3 Paper & paperboard
  • 6.4 Glass
  • 6.5 Metal

Chapter 7 Market Estimates and Forecast, By Packaging Type, 2021 – 2034 (USD Bn & Kilo Tons)

  • 7.1 Key trends
  • 7.2 Primary packaging
  • 7.3 Secondary packaging
  • 7.4 Tertiary packaging

Chapter 8 Market Estimates and Forecast, By Application, 2021 – 2034 (USD Bn & Kilo Tons)

  • 8.1 Key trends
  • 8.2 Oral drugs
  • 8.3 Injectable drugs
  • 8.4 Topical drugs
  • 8.5 Nasal drugs
  • 8.6 Intravenous (IV) drugs
  • 8.7 Others

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 (USD Bn & Kilo Tons)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Adelphi
  • 10.2 Amcor
  • 10.3 Aptar CSP Technologies
  • 10.4 Berry Global
  • 10.5 Catalent
  • 10.6 CCL Industries
  • 10.7 Comar
  • 10.8 Constantia Flexibles
  • 10.9 Drug Plastics & Glass
  • 10.10 DS Smith
  • 10.11 Eastman Chemical
  • 10.12 Gerresheimer
  • 10.13 Huhtamaki
  • 10.14 Mayr-Melnhof Karton
  • 10.15 Nipro
  • 10.16 Origin Pharma Packaging
  • 10.17 ProAmpac
  • 10.18 Schott Pharma
  • 10.19 SGD Pharma
  • 10.20 Silgan
  • 10.21 Sonoco
  • 10.22 West Pharmaceutical
  • 10.23 WestRock